Changes of serum midkine as a dynamic prognostic factor to monitor disease status in papillary thyroid cancer

AbstractThis study aimed to investigate the value of dynamic changes of midkine (MK) to monitor post-surgical patients with papillary thyroid cancer (PTC) who were managed with 131I therapies.MK concentration at initial 131I ablation therapy (MK1) as well as 10 to 12 months thereafter (MK2) was eval